Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.82
+0.23 (1.69%)
At close: Oct 8, 2025, 4:00 PM EDT
13.82
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT
Carlsmed Revenue
Carlsmed had revenue of $12.08M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $38.27M. In the year 2024, Carlsmed had annual revenue of $27.17M with 97.16% growth.
Revenue (ttm)
$38.27M
Revenue Growth
+97.16%
P/S Ratio
1.52
Revenue / Employee
$430,000
Employees
89
Market Cap
367.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
Dec 31, 2023 | 13.78M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 9 days ago - Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary - GlobeNewsWire
- 16 days ago - Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index - GlobeNewsWire
- 5 weeks ago - UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Carlsmed® Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - GlobeNewsWire
- 2 months ago - Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - GlobeNewsWire
- 2 months ago - Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery - GlobeNewsWire
- 2 months ago - Carlsmed: Spine Play Does Not Have My Backing Yet - Seeking Alpha